Immediate Impact
57 standout
Citing Papers
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
2023 Standout
Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regression
2023 Standout
Works of Graeme Archer being referenced
Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder
2011
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Graeme Archer | 23 | 68 | 36 | 182 | 84 | 14 | 479 | |
| Shubhra Mace | 2 | 25 | 2 | 273 | 123 | 14 | 459 | |
| R T Owen | 3 | 29 | 5 | 206 | 119 | 9 | 573 | |
| Flavio Pozzi | 38 | 3 | 176 | 70 | 11 | 440 | ||
| Montserrat Maurí | 1 | 96 | 21 | 122 | 36 | 19 | 474 | |
| Maria Tome | 3 | 54 | 2 | 128 | 142 | 17 | 449 | |
| P Dick | 1 | 50 | 5 | 171 | 58 | 24 | 450 | |
| Kenneth B. Kashkin | 3 | 85 | 231 | 116 | 7 | 502 | ||
| Colette Kosik‐Gonzalez | 6 | 12 | 3 | 362 | 160 | 18 | 534 | |
| Joseph Pultz | 2 | 66 | 1 | 290 | 81 | 11 | 515 | |
| Erzsébet Szalai | 1 | 47 | 316 | 69 | 12 | 419 |
All Works
Loading papers...